Lotan, Amit http://orcid.org/0000-0001-7628-0975
Luza, Sandra
Opazo, Carlos M. http://orcid.org/0000-0003-3473-7548
Ayton, Scott http://orcid.org/0000-0002-3479-2427
Lane, Darius J. R.
Mancuso, Serafino
Pereira, Avril
Sundram, Suresh http://orcid.org/0000-0002-9674-0227
Weickert, Cynthia Shannon
Bousman, Chad http://orcid.org/0000-0001-6303-8696
Pantelis, Christos http://orcid.org/0000-0002-9565-0238
Everall, Ian P.
Bush, Ashley I. http://orcid.org/0000-0001-8259-9069
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1194028, 1196508)
Israel Science Foundation (2343/18)
Article History
Received: 5 November 2022
Revised: 10 January 2023
Accepted: 20 January 2023
First Online: 7 February 2023
Change Date: 20 February 2023
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Competing interests
: AIB holds equity in Alterity Ltd, Cogstate Ltd, Mesoblast Ltd and a profit-share in Collaborative Medicinal Development Pty Ltd.